The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and the hemoglobin, albumin, lymphocyte, and platelet score (HALP) have the potential to function as predictors of prognosis for NSCLC patients following surgery (21–23). This evidence concerns the gene ALB and non-small cell lung carcinoma.